Statins Evaluation in Coronary Procedures and Revascularization Trial

• Status: Completed
• Trial end date: 2018-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether a loading dose of atorvastatin before percutaneous intervention procedures in acute coronary syndromes is effective to reduce major cardiovascular events(MACE).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital do Coracao
• Collaborator: Ministry of Health, Brazil
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• Acute coronary syndrome patients intending to undergo percutaneous coronary intervention.

Exclusion Criteria:

• Younger than 18 years

• Presence of any contraindication to statin (Pregnant women, breast-feeding women or statin hypersensibility)

• Advanced hepatic disease

• Use of statins at the maximum dosage in the last 24 hours before the loading dose of the study drug

• Use of fibrate in the last 24 hours